Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice-Reference-Cited by-同舟云学术

Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice

Published:2021-11-25 Issue: Volume: Page:
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Xiao Ting,Cui Mengqi,Zheng Caijuan,Zhang Peipei,Ren Shanfa,Bao Jiali,Gao Dandi,Sun Ronghao,Wang Ming,Lin Jianping,Zhang Liang,Li Mingjiang,Li Dongmei,Zhou Honggang^ORCID,Yang Cheng

Funder

tianjin science and technology committee

fundamental research funds for the central universities

Fundamental Research Funds for the Central Universities

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s10753-021-01602-z.pdf

Reference38 articles.

1. Ciotti, M., S. Angeletti, M. Minieri, M. Giovannetti, D. Benvenuto, S. Pascarella, C. Sagnelli, M. Bianchi, S. Bernardini, and M. Ciccozzi. 2019. COVID-19 Outbreak: An Overview. Chemotherapy 64: 215–223.

2. Tandon, P.N. 2020. COVID-19: Impact on health of people & wealth of nations. Indian Journal of Medical Research 151: 121–123.

3. Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine A. 2020. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). Zhonghua Liu Xing Bing Xue Za Zhi 41:139–144.

4. Wang, H.J., S.H. Du, X. Yue, and C.X. Chen. 2020. Review and Prospect of Pathological Features of Corona Virus Disease. Fa Yi Xue Za Zhi 36: 16–20.

5. Gupta, S.P. 2020. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Current Topics in Medicinal Chemistry 20: 2362–2378.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease;Archiv der Pharmazie;2024-08-15

2. Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro;Inflammopharmacology;2024-07-24

3. Comparative evaluation of the biological activity of quercetin-like compounds;Health and Ecology Issues;2024-03-28

4. Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors;Journal of Medical Virology;2024-03

5. AI-driven covalent drug design strategies targeting main protease (m ^pro ) against SARS-CoV-2: structural insights and molecular mechanisms;Journal of Biomolecular Structure and Dynamics;2024-01-29